HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

intravenous (IV) ganciclovir

TERMINATED · PHASE4 · Acute Renal Failure, Cytomegalovirus Infections, Multi Organ Failure

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.